Key Metrics
8.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
1.92
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Clinical trial
- Psoriasis
- Vaginal atrophy
- Postmenopausal women
- Ribavirin
- Treatment options
- Breast cancer
- Rheumatoid arthritis
- Type 2 diabetes
- Ulcerative colitis
- Type 2 Diabetes Mellitus
- Ketamine
- Janus kinase inhibitor
- Heart failure
- Atopic dermatitis
- Response analysis
- Sofosbuvir
- Sore throat
- Immunotherapy
- Psoriatic arthritis
Journal Specifications
| Overview | |
| Publisher | BioExcel Publishing Ltd |
| Language | English |
| Article Processing Charges | GBP 1550 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 9 |
| Article Processing Charges | GBP 1550 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Drugs in Context ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers.
- 29 Apr 24
- Drugs in context
-
Full paper
Assessment of knowledge, attitude and practice of fixed-dose combinations amongst attending physicians and residents: a cross-sectional evaluation.
- 25 Apr 24
- Drugs in context
-
Full paper
Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings.
- 22 Apr 24
- Drugs in context
-
Full paper
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial.
- 5 Apr 24
- Drugs in context
-
Full paper
Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts.
- 26 Mar 24
- Drugs in context
-
Full paper
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study.
- 18 Mar 24
- Drugs in context
Scite analysis
Powered by scite_
493 articles received 5.6k citations see all
- 113 Supporting
- 5,202 Mentioning
- 16 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 7 Errata
- 0 Expression of Concern
FAQs
How many articles did Drugs in Context publish last years ?
In 2023, Drugs in Context published 64 articles.
What is the eISSN & pISSN for Drugs in Context ?
For Drugs in Context,eISSN is 1740-4398 and pISSN is1745-1981.
What is Citescore for Drugs in Context ?
Citescore for Drugs in Context is 8.1.
What is SNIP score for Drugs in Context ?
SNIP score for Drugs in Context is 1.92.
Who is the publisher of Drugs in Context ?
BioExcel Publishing Ltd is the publisher of Drugs in Context.